The Role of Vaccinations: Past, Present and Future image

The Role of Vaccinations: Past, Present and Future

Aug 11, 2021
02:00PM - 03:00PM EDT
Online Event
Overview

Dr. David Avigan from Beth-Israel Deaconess Medical Center joins us to talk about the different categories of vaccinations, the role of vaccinations post-transplant, and the future role of vaccines in myeloma treatment. Come with your questions!

Agenda
02:00 PM
Introduction
Audrey Burton-Bethke
Audrey welcomes everyone, introduces our featured guest, and shares the event agenda.
02:05 PM
Presentation
David Avigan, MD
Dr. Avigan presents the difference between the three categories of vaccinations, the role of vaccinations post-transplant, and the current and future role of vaccines in myeloma immunotherapy treatment. 
02:50 PM
Q & A
Audience
Dr. Avigan answers the audience's questions about the presentation and vaccinations.
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact David E. Avigan, MD

David E. Avigan, MD

David Avigan, MD is Chief of Division of Hematology and Hematologic Malignancies at the Beth Israel Deaconess Medical Center in Boston, Massachusetts, and is a Professor of Medicine at Harvard Medical School. Dr. Avigan's clinical interests include multiple myeloma, lymphoma, leukemia, cellular therapy, CAR T-cell therapy, immunotherapy, and all bone marrow transplant services. His board certifications include the American Board of Internal Medicine, the American Board of Internal Medicine (Hematology), and the American Board of Internal Medicine (Medical Oncology). Dr. Avigan graduated from the Yale University School of Medicine, completed his residency at Columbia Presbyterian Medical Center, and a fellowship at the Memorial Sloan-Kettering Cancer Center. Dr. Avigan is fluent in English, Hebrew and Spanish.